Dr. Gissou Azabdaftari Gissou Azabdaftari, MD

Gissou Azabdaftari

MD
Anatomic Pathology

Specializing In:

Oncologic surgical pathology with emphasis on genito-urologic tumors Bone and soft tissue tumors Cytology

Special Interests:

Histo-morphologic diagnosis, classification and staging of urologic and male organ genitals, bone and soft tissue tumors Translational research and tissue banking Performing and interpretation of fine needle aspirations
About Gissou Azabdaftari

Positions

Roswell Park Comprehensive Cancer Center
  • Chief, Division of Cytopathology
  • Associate Professor of Oncology
  • Department of Pathology & Laboratory Medicine
  • Department of Urology

Background

Education and Training:

  • 1987-1994 - University of Bologna, Bologna, Italy

Residency:

  • 2000-2004 - Tufts-New England Medical Center, Boston, MA

Fellowship:

  • 2005-2006 - Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (Cytopathology)
  • 2004-2005 - Brigham and Women's Hospital, Harvard Medical School, Boston, MA (Genitourinary Pathology/Soft Tissue Pathology)

Board Certification:

  • Board Certified in Anatomic Pathology
  • American Board of Cytopathology

Professional Memberships:

  • United States and Canadian Academy of Pathology
  • American Society for Clinical Pathology
  • College of American Pathologists

Publications

Full Publications list on PubMed
  • Foster BA, Gangavarapu KJ, Mathew G, Azabdaftari G, Morrison CD, Miller A, Huss WJ. Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. PLoS One. 2013;8(1):e55062. doi: 10.1371/journal.pone.0055062. Epub 2013 Jan 31. PMID: 23383057; PMCID: PMC3561453.
  • Koochekpour S, Majumdar S, Azabdaftari G, Attwood K, Scioneaux R, Subramani D, Manhardt C, Lorusso GD, Willard SS, Thompson H, Shourideh M, Rezaei K, Sartor O, Mohler JL, Vessella RL. Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res. 2012 Nov 1;18(21):5888-901. doi: 10.1158/1078-0432.CCR-12-1308. Epub 2012 Oct 16. PMID: 23072969; PMCID: PMC3492499.
  • Karacosta LG, Foster BA, Azabdaftari G, Feliciano DM, Edelman AM. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression. J Biol Chem. 2012 Jul 13;287(29):24832-43. doi: 10.1074/jbc.M112.370783. Epub 2012 May 31. PMID: 22654108; PMCID: PMC3397910.
  • Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, Azabdaftari G, Nakaso K, Yan Z, Feng J. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun. 2012 Feb 7;3:668. doi: 10.1038/ncomms1669. PMID: 22314364; PMCID: PMC3498452.
  • Koochekpour S, Hu S, Vellasco-Gonzalez C, Bernardo R, Azabdaftari G, Zhu G, Zhau HE, Chung LW, Vessella RL. Serum prosaposin levels are increased in patients with advanced prostate cancer. Prostate. 2012 Feb;72(3):253-69. doi: 10.1002/pros.21427. Epub 2011 May 31. Erratum in: Prostate. 2014 May;74(7):804. PMID: 21630292; PMCID: PMC3406735.
  • Ellis L, Shah P, Hammers H, Lehet K, Sotomayor P, Azabdaftari G, Seshadri M, Pili R. Vascular disruption in combination with mTOR inhibition in renal cell carcinoma. Mol Cancer Ther. 2012 Feb;11(2):383-92. doi: 10.1158/1535-7163.MCT-11-0748. Epub 2011 Nov 14. PMID: 22084164; PMCID: PMC3766330.
  • Azabdaftari G, Goldberg SN, Wang HH. Efficacy of on-site specimen adequacy evaluation of image-guided fine and core needle biopsies. Acta Cytol. 2010 Mar-Apr;54(2):132-7. doi: 10.1159/000324997. PMID: 20391967.

Request an Appointment

Make an appointment by calling 1-800-ROSWELL (1-800-767-9355)

Make an Appointment